Optima Health (LON:OPT) Price Target Raised to GBX 220 at Royal Bank of Canada

Optima Health (LON:OPT) had its price target upped by analysts at Royal Bank of Canada from GBX 215 ($2.83) to GBX 220 ($2.90) in a note issued to investors on Tuesday,London Stock Exchange reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 22.22% from the company’s previous close.

Optima Health Stock Up 2.9 %

Shares of LON:OPT traded up GBX 5 ($0.07) on Tuesday, reaching GBX 180 ($2.37). 140,539 shares of the company were exchanged, compared to its average volume of 210,161. The stock’s 50-day simple moving average is GBX 178.01. Optima Health has a 1-year low of GBX 139 ($1.83) and a 1-year high of GBX 201.95 ($2.66).

Optima Health Company Profile

Optima Health is the UK’s leading provider of technology enabled corporate health and wellbeing solutions in the occupational health sector.

Underpinned by a robust clinical governance framework, the Group leverages its proprietary technology and flexible delivery platform to foster healthy high performance within its clients’ workforces.

The Group offers a comprehensive range of flexible and progressive services from statutory driven workplace health surveillance medicals to proactive and preventive interventions, through to workplace health advice and attendance management assessments, and clinically effective rehabilitation programmes and pathways aimed at returning people to work.